IMM 0.60% 41.8¢ immutep limited

Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC, page-29

  1. 5,246 Posts.
    lightbulb Created with Sketch. 1641
    My friend, since yesterday only some 30mil shares have been traded on ASX. This does not even meet the threshold for substantial number of shares which is by definition 5% of the registry. These small number of shares will for ever be fluid no matter what, as they are in the hands of short term traders. OVER 97% of the company has held on to their shates and to them the potentisls have not changed!!!!

    So, Please tell me why the company strategy should change, to then dance to the tune of afew, most of whom don't give a rat's arse about the broader objectives as to them a biotech is the same as crypto as far as trading it is concerned.

    SO NO, I WOULD NOT WANT THE MANAGEMENT DANCE TO THE TUNE OF SHORT TERM TRADERS AND QUICK PROFIT MAKERS.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
41.8¢
Change
-0.003(0.60%)
Mkt cap ! $594.7M
Open High Low Value Volume
41.5¢ 42.0¢ 41.0¢ $428.7K 1.038M

Buyers (Bids)

No. Vol. Price($)
16 134629 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 123625 15
View Market Depth
Last trade - 14.33pm 25/06/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.